Soleus Capital Management, L.P. Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$103.7B
Holdings
49
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (49 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | GRFSGRIFOLS S A | 452,900 | $10.5B | 10.17% | |
| 2 | EPIEURESSA PHARMA INC | 1,634,369 | $9.0B | 8.67% | |
| 3 | —WRIGHT MED GROUP N V | 226,700 | $6.9B | 6.66% | |
| 4 | OPHTEURIVERIC BIO INC | 668,371 | $5.7B | 5.53% | |
| 5 | —ALLERGAN PLC | 28,500 | $5.4B | 5.25% | |
| 6 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 342,800 | $3.9B | 3.81% | |
| 7 | DC4DEXCOM INC | 17,600 | $3.8B | 3.71% | |
| 8 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 458,165 | $3.5B | 3.38% | |
| 9 | ALXNALEXION PHARMACEUTICALS INC | 31,300 | $3.4B | 3.26% | |
| 10 | —MISONIX INC | 178,596 | $3.3B | 3.21% | |
| 11 | IRMDIRADIMED CORP | 140,752 | $3.3B | 3.17% | |
| 12 | VCELVERICEL CORP | 183,680 | $3.2B | 3.08% | |
| 13 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 205,407 | $3.1B | 2.95% | |
| 14 | ESTAESTABLISHMENT LABS HLDGS INC | 93,560 | $2.6B | 2.50% | |
| 15 | —DERMIRA INC | 164,600 | $2.5B | 2.41% | |
| 16 | AXGNAXOGEN INC | 127,450 | $2.3B | 2.20% | |
| 17 | BIIBBIOGEN INC | 7,500 | $2.2B | 2.15% | |
| 18 | HUMHUMANA INC | 5,800 | $2.1B | 2.05% | |
| 19 | XENEXENON PHARMACEUTICALS INC | 161,600 | $2.1B | 2.04% | |
| 20 | 2L9BLUEPRINT MEDICINES CORP | 26,400 | $2.1B | 2.04% | |
| 21 | —CONSTELLATION PHARMCETICLS I | 42,100 | $2.0B | 1.91% | |
| 22 | AM6AMICUS THERAPEUTICS INC | 188,800 | $1.8B | 1.77% | |
| 23 | —HARPOON THERAPEUTICS INC | 123,200 | $1.8B | 1.76% | |
| 24 | —KADMON HLDGS INC | 350,300 | $1.6B | 1.53% | |
| 25 | CRSPCRISPR THERAPEUTICS AG | 22,300 | $1.4B | 1.31% | |
| 26 | STESTERIS PLC | 8,800 | $1.3B | 1.29% | |
| 27 | STAASTAAR SURGICAL CO | 35,940 | $1.3B | 1.22% | |
| 28 | —ZYMEWORKS INC | 22,700 | $1.0B | 0.99% | |
| 29 | NVROEURNEVRO CORP | 8,246 | $969.0M | 0.93% | |
| 30 | —ZEALAND PHARMA A S | 26,882 | $892.0M | 0.86% | |
| 31 | —ZAFGEN INC | 803,963 | $892.0M | 0.86% | |
| 32 | ICADUSDICAD INC | 94,900 | $737.0M | 0.71% | |
| 33 | —FLEXION THERAPEUTICS INC | 34,900 | $722.0M | 0.70% | |
| 34 | RFLRAFAEL HLDGS INC | 37,925 | $676.0M | 0.65% | |
| 35 | INSPINSPIRE MED SYS INC | 9,008 | $668.0M | 0.64% | |
| 36 | ARNAEURARENA PHARMACEUTICALS INC | 11,100 | $504.0M | 0.49% | |
| 37 | TNDMTANDEM DIABETES CARE INC | 7,600 | $453.0M | 0.44% | |
| 38 | NTRANATERA INC | 13,000 | $437.0M | 0.42% | |
| 39 | LVGOLIVONGO HEALTH INC | 16,866 | $422.0M | 0.41% | |
| 40 | ESPRESPERION THERAPEUTICS INC NE | 6,700 | $399.0M | 0.38% | |
| 41 | GHGUARDANT HEALTH INC | 4,900 | $382.0M | 0.37% | |
| 42 | RVNCEURREVANCE THERAPEUTICS INC | 23,200 | $376.0M | 0.36% | |
| 43 | ARVNARVINAS INC | 8,700 | $357.0M | 0.34% | |
| 44 | PTCTPTC THERAPEUTICS INC | 6,800 | $326.0M | 0.31% | |
| 45 | ARGXARGENX SE | 1,500 | $240.0M | 0.23% | |
| 46 | SWAVUSDSHOCKWAVE MED INC | 5,400 | $237.0M | 0.23% | |
| 47 | —DICERNA PHARMACEUTICALS INC | 10,700 | $235.0M | 0.23% | |
| 48 | FATEFATE THERAPEUTICS INC | 11,400 | $223.0M | 0.22% | |
| 49 | SNDXSYNDAX PHARMACEUTICALS INC | 20,980 | $184.0M | 0.18% |